Related Experiment Video
Updated: Nov 9, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Novel double beta-lactam therapy for Granulicatella adiacens infective endocarditis
1The Dr. James J. Rahal, Jr. Division of Infectious Diseases, NewYork-Presbyterian Queens, 56-45 Main Street, Flushing, NY, 11355, USA.
Abstract:
Granulicatella adiacens, a nutritionally variant streptococci (NVS) is a well described organism associated with endocarditis. Previously communicated cases have documented the use of double beta-lactam therapy with ampicillin and ceftriaxone to treat patients with infective endocarditis due to Enterococcus faecalis and Streptocossus pneumoniae. We describe the first case of Granulicatella adiacens infective endocarditis in a patient successfully treated with the combination of intravenous ampicillin and ceftriaxone and document their synergistic activity.
Insights
This study presents the first successful treatment of Granulicatella adiacens endocarditis using ampicillin and ceftriaxone. The combination therapy demonstrated synergistic activity against this rare bacterial infection.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Granulicatella adiacens, a nutritionally variant streptococci (NVS), is a known cause of infective endocarditis.
- Previous studies have shown efficacy of dual beta-lactam therapy for endocarditis caused by other bacteria.
Observation:
- A case of infective endocarditis caused by Granulicatella adiacens is described.
- The patient was treated with a combination of intravenous ampicillin and ceftriaxone.
Findings:
- This is the first reported case of Granulicatella adiacens endocarditis successfully treated with ampicillin and ceftriaxone.
- The study documents the synergistic activity of this antibiotic combination against Granulicatella adiacens.
Implications:
- Ampicillin and ceftriaxone combination therapy is a viable treatment option for Granulicatella adiacens endocarditis.
- This finding expands treatment options for rare infectious endocarditis cases.
- Further research into synergistic antibiotic combinations for NVS infections is warranted.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

